Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Malkin

Showing results (161-170 of 270) with videos related to

Pageof 27
Sort By:
Plos Genetics|January 6, 2025
Leveraging cancer mutation data to inform the pathogenicity classification of germline missense variantsBushra Haque, David Cheerie, Amy Pan, et al.
Nature Communications|August 27, 2024
Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patternsDerek Wong, Maha Tageldein, Ping Luo, et al.
The Lancet. Oncology|August 10, 2016
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational studyAnita Villani, Ari Shore, Jonathan D Wasserman, et al.
The Journal of Pathology|June 26, 2019
Integrative genomic analysis of matched primary and metastatic pediatric osteosarcomaGian Luca Negri, Bruno M Grande, Alberto Delaidelli, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Myeloproliferative Neoplasm Driven by <i>ETV6-ABL1</i> in an Adolescent with Recent History of Burkitt LeukemiaSamuele Renzi, Fatimah Algawahmed, Scott Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancerDebra G B Leonard, Lois B Travis, Kathakali Addya, et al.
Pediatric Blood & Cancer|October 13, 2011
Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010Alexa E Gozali, Barbara Britt, Lisa Shane, et al.
American Journal of Human Genetics|November 9, 2010
A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromesAdam Shlien, Berivan Baskin, Maria Isabel W Achatz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
TP53 mutations and outcome in osteosarcoma: a prospective, multicenter studyJay S Wunder, Nalan Gokgoz, Robert Parkes, et al.
Cancer Biology & Therapy|December 2, 2011
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohortRobert K Nam, William Zhang, Katherine Siminovitch, et al.
Pageof 27

Showing results (161-170 of 270) with videos related to

Sort By:
Pageof 27
Plos Genetics|January 6, 2025
Leveraging cancer mutation data to inform the pathogenicity classification of germline missense variantsBushra Haque, David Cheerie, Amy Pan, et al.
Nature Communications|August 27, 2024
Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patternsDerek Wong, Maha Tageldein, Ping Luo, et al.
The Lancet. Oncology|August 10, 2016
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational studyAnita Villani, Ari Shore, Jonathan D Wasserman, et al.
The Journal of Pathology|June 26, 2019
Integrative genomic analysis of matched primary and metastatic pediatric osteosarcomaGian Luca Negri, Bruno M Grande, Alberto Delaidelli, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Myeloproliferative Neoplasm Driven by <i>ETV6-ABL1</i> in an Adolescent with Recent History of Burkitt LeukemiaSamuele Renzi, Fatimah Algawahmed, Scott Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancerDebra G B Leonard, Lois B Travis, Kathakali Addya, et al.
Pediatric Blood & Cancer|October 13, 2011
Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010Alexa E Gozali, Barbara Britt, Lisa Shane, et al.
American Journal of Human Genetics|November 9, 2010
A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromesAdam Shlien, Berivan Baskin, Maria Isabel W Achatz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
TP53 mutations and outcome in osteosarcoma: a prospective, multicenter studyJay S Wunder, Nalan Gokgoz, Robert Parkes, et al.
Cancer Biology & Therapy|December 2, 2011
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohortRobert K Nam, William Zhang, Katherine Siminovitch, et al.
Pageof 27